The ideal inhaler for asthma therapy

Innovations in multidose nebulisers and dry-powder inhalation devices have been stimulated by the development of new chemical entities and the availability of generic drugs. In addition, conventional pressurised inhalers are being replaced because of the phasing-out of chlorofluorocarbon gases. This article highlights the key features that constitute the ideal inhaler.